116 related articles for article (PubMed ID: 2412301)
1. [Treatment of non-Hodgkin's lymphomas with CHOP-bleo. Experience in 16 patients].
González Brito G; Marsá Vilá L; Chávez MI; Batista López N; Hernández Nieto L
Sangre (Barc); 1985; 30(3):367-8. PubMed ID: 2412301
[No Abstract] [Full Text] [Related]
2. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
Sampi K; Honda T; Hattori M; Takayama S
Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
[TBL] [Abstract][Full Text] [Related]
3. Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.
Miller TP; Dana BW; Weick JK; Jones SE; Coltman CA; Dahlberg S; Fisher RI
Semin Hematol; 1988 Apr; 25(2 Suppl 2):17-22. PubMed ID: 2456619
[TBL] [Abstract][Full Text] [Related]
4. [Results of treating lymphomas with high degree of malignancy using COPP, CHOP-Bleo and MEV protocols].
Płuzańska A; Krykowski E; Robak T; Oliskiewicz W; Polkowska E; Dowgier I; Hyjek E
Pol Tyg Lek; 1982 Sep; 37(36):1049-53. PubMed ID: 6189105
[No Abstract] [Full Text] [Related]
5. [Therapy of non-Hodgkin's lymphoma].
Schaadt M; Plaumann L; Diehl V
Dtsch Med Wochenschr; 1984 Feb; 109(7):261-5. PubMed ID: 6199176
[No Abstract] [Full Text] [Related]
6. Non Hodgkin's lymphomas: prognostic feature of 55 patients treated with MEVAP chemotherapy.
Mazza P; Lauria F; Gherlinzoni F; Fiacchini M; Galieni P; Tura S
Haematologica; 1984; 69(2):178-87. PubMed ID: 6429003
[No Abstract] [Full Text] [Related]
7. [Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
Bron D; Vandenheule B; Stryckmans P
Rev Med Brux; 1985 Sep; 6(7):491-5. PubMed ID: 2417298
[No Abstract] [Full Text] [Related]
8. Hematologic malignancies: non-Hodgkin's lymphomas.
DeVita VT
Hosp Pract (Off Ed); 1986 Sep; 21(9):103-18. PubMed ID: 2427535
[No Abstract] [Full Text] [Related]
9. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
10. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
11. [Preinduction in the treatment of patients with malignant lymphoma].
Avilés A; García EL; Talavera A; Guzmán R; Diáz-Maqueo JC
Gac Med Mex; 1991; 127(2):119-23. PubMed ID: 1720407
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
13. A comparative study with COP and COP-Bleo combination chemotherapy in advanced (non-Hodgkin's) lymphomas.
Kaku K; Inoue M; Fujii S; Ishida Y; Hiroshige Y; Shinohara K; Nakashima K; Matsumoto N; Kaneko T
Nihon Ketsueki Gakkai Zasshi; 1983 Jul; 46(4):940-6. PubMed ID: 6195877
[No Abstract] [Full Text] [Related]
14. European experience with ifosfamide in lymphomas.
von Kalle AK; Schaadt M; Diehl V
Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
[TBL] [Abstract][Full Text] [Related]
15. Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up.
Björkholm M; Celsing F; Johansson E;
Ann Hematol; 2006 Oct; 85(10):731-3. PubMed ID: 16838163
[No Abstract] [Full Text] [Related]
16. [Remission maintenance therapy of non-Hodgkin's lymphoma with CHOP protocol].
Toki H; Okabe K; Ishikawa M; Fujii M; Kimura Y
Gan To Kagaku Ryoho; 1984 Feb; 11(2):260-4. PubMed ID: 6546489
[TBL] [Abstract][Full Text] [Related]
17. Brief induction chemotherapy followed by involved-field irradiation for the treatment of localized intermediate- and high-grade non-Hodgkin's lymphoma.
Ohnoshi T; Hayashi K; Mizuta J; Tagawa S; Matsutomo S; Saito S; Kawashima K; Akagi T; Kimura I
Int J Hematol; 1993 Jan; 57(1):61-6. PubMed ID: 7682860
[TBL] [Abstract][Full Text] [Related]
18. ProMACE-CytaBOM: combination chemotherapy for diffuse large cell lymphoma.
Prokocimer M; Modan M; Rusoshansky S; Bairey O; Shaklai M
Anticancer Res; 1989; 9(4):1233-5. PubMed ID: 2479327
[TBL] [Abstract][Full Text] [Related]
19. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone).
Voulgarelis M; Giannouli S; Tzioufas AG; Moutsopoulos HM
Ann Rheum Dis; 2006 Aug; 65(8):1033-7. PubMed ID: 16322082
[TBL] [Abstract][Full Text] [Related]
20. Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
Konopka L; Pawelski S
J Chemother; 1989 Jul; 1(4 Suppl):1259-62. PubMed ID: 16312857
[No Abstract] [Full Text] [Related]
[Next] [New Search]